Gentherm Announces Participation in Upcoming Roth Conference
Rhea-AI Summary
Gentherm (NASDAQ: THRM) will participate in the 38th Annual ROTH Conference in Dana Point, California. Bill Presley, President and CEO, and Jon Douyard, Executive Vice President, Chief Financial Officer and Treasurer, will host investor meetings on March 23–24, 2026.
Event dates and participation are subject to change; investors should check the Gentherm Investor Relations website for the latest scheduling and registration details.
Positive
- None.
Negative
- None.
News Market Reaction – THRM
In the Mar 11 session, THRM gained 0.80%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 10 | Medical product PR | Positive | -0.5% | Agency appointed to support ThermAffyx launch ahead of expected FDA clearance. |
| Feb 19 | Earnings and guidance | Positive | +1.3% | Record 2025 revenues, strong cash flow, new awards and 2026–2027 outlook. |
| Feb 05 | Earnings date notice | Neutral | -1.0% | Scheduled Q4 and full-year 2025 earnings release and conference call details. |
| Feb 03 | FDA 510(k) submission | Positive | -1.8% | 510(k) filing for ThermAffyx system with launch targeted in Q3 2026. |
| Jan 29 | Business combination | Positive | -0.6% | Reverse Morris Trust with Modine Performance Technologies to form larger thermal platform. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent fundamentally positive announcements (M&A, FDA-related, record results) often saw flat-to-negative next-day moves, while only the detailed earnings release aligned with a positive price reaction.
Over the last few months, Gentherm has reported record 2025 product revenues, issued 2026–2027 guidance, and announced a planned Reverse Morris Trust combination with Modine’s Performance Technologies creating a $2.6B thermal management business. It has also advanced its ThermAffyx™ surgical warming and securement system through a 510(k) submission and related communications. Despite these milestones, several news days saw negative price reactions, suggesting a cautious market tone into which this Roth Conference participation update arrives.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NOVI, Mich., March 11, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that it is scheduled to participate in the 38th Annual ROTH Conference in Dana Point, California. Bill Presley, President and CEO, and Jon Douyard, Executive Vice President, Chief Financial Officer and Treasurer, will be hosting investors on Monday, March 23, 2026 and Tuesday, March 24, 2026.
Please note that event participation and specific dates are subject to change. For the latest information, please visit the Gentherm Investor Relations website.
Investor Contact
Gregory Blanchette
investors@gentherm.com
248.308.1702
Media Contact
Haley Baur
media@gentherm.com
258.289.9711
About Gentherm
Gentherm (NASDAQ: THRM) is a global market leader of innovative thermal management and pneumatic comfort technologies. Automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, and Valve Systems. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities across 13 countries. In 2025, the company recorded annual sales of approximately
